Dr. Monk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1999 - 2002
- OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1996 - 1999
- Ohio State University College of MedicineClass of 1996
Certifications & Licensure
- OH State Medical License 1999 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma Start of enrollment: 2006 Nov 08
- Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer Start of enrollment: 2008 Feb 01
- Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Oct 29
- Join now to see all
Publications & Presentations
PubMed
- 128 citationsAssessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer PatientsJ. Paul Monk, Gary Phillips, Ross E. Waite, John G. Kuhn, Larry J. Schaaf
Journal of Clinical Oncology. 2006-04-20 - 366 citationsRandomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant...William Kevin Kelly, Susan Halabi, Michael A. Carducci, Daniel J. George, John Francis Mahoney
Journal of Clinical Oncology. 2012-05-01 - 4 citationsEffects of a lifestyle intervention on body composition in prostate cancer patients on androgen deprivation therapy.Zachary L Chaplow, Brian C Focht, Alexander R Lucas, Elizabeth Grainger, Christina Simpson
JCSM Clinical Reports. 2020-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: